Clinical Trial: Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)

U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07246889) titled 'Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)' on Aug. 12.

Brief Summary: This study is a randomized, double-blind, multicenter phase 3 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with HBeAg-negative CHB treated with NAs.

Study Start Date: Aug. 12

Study Type: INTERVENTIONAL

Condition: Chronic Hepatitis B

Intervention: DRUG: AHB-137

AHB-137 will be injected weekly by subcutaneous injection. There are 2 leading doses on day 4 and day 11.

DRUG: Placebo

Placebo will be injected weekly by subcutaneous injection.Two a...